Olaf Hoffmann

1.9k total citations
45 papers, 518 citations indexed

About

Olaf Hoffmann is a scholar working on Neurology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Olaf Hoffmann has authored 45 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 11 papers in Pathology and Forensic Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Olaf Hoffmann's work include Organ Donation and Transplantation (11 papers), Multiple Sclerosis Research Studies (11 papers) and Traumatic Brain Injury and Neurovascular Disturbances (6 papers). Olaf Hoffmann is often cited by papers focused on Organ Donation and Transplantation (11 papers), Multiple Sclerosis Research Studies (11 papers) and Traumatic Brain Injury and Neurovascular Disturbances (6 papers). Olaf Hoffmann collaborates with scholars based in Germany, United States and Switzerland. Olaf Hoffmann's co-authors include Stephan Patt, K. Jendroska, Florian Masuhr, José M. Valdueza, Karl M. Einhäupl, Florian Doepp, S. Mehraein, Markus Weih, C. Hornig and W. Dorndorf and has published in prestigious journals such as Neurology, Stroke and Annals of the New York Academy of Sciences.

In The Last Decade

Olaf Hoffmann

42 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf Hoffmann Germany 15 173 119 112 79 72 45 518
Evangelia E. Tsironi Greece 18 157 0.9× 145 1.2× 60 0.5× 79 1.0× 63 0.9× 62 856
David Ozretić Croatia 13 155 0.9× 108 0.9× 62 0.6× 66 0.8× 43 0.6× 58 447
Masatoshi Yunoki Japan 14 158 0.9× 74 0.6× 131 1.2× 49 0.6× 36 0.5× 51 521
Claus Vinter Bødker Hviid Denmark 12 195 1.1× 60 0.5× 50 0.4× 72 0.9× 59 0.8× 40 469
Keith A. Kattner United States 13 180 1.0× 63 0.5× 154 1.4× 85 1.1× 99 1.4× 22 583
Isabelle Korn‐Lubetzki Israel 11 162 0.9× 56 0.5× 91 0.8× 42 0.5× 41 0.6× 35 472
Tatsuo Akimura Japan 17 329 1.9× 141 1.2× 87 0.8× 70 0.9× 31 0.4× 52 723
Panagiotis Toulas Greece 16 225 1.3× 53 0.4× 83 0.7× 35 0.4× 47 0.7× 42 525
Vianney Gilard France 16 211 1.2× 105 0.9× 52 0.5× 126 1.6× 26 0.4× 45 638
Daniel R. LeMay United States 12 107 0.6× 117 1.0× 78 0.7× 93 1.2× 58 0.8× 17 503

Countries citing papers authored by Olaf Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Olaf Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Hoffmann more than expected).

Fields of papers citing papers by Olaf Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Hoffmann. The network helps show where Olaf Hoffmann may publish in the future.

Co-authorship network of co-authors of Olaf Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Hoffmann. A scholar is included among the top collaborators of Olaf Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Hoffmann. Olaf Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salih, Farid, Johann Lambeck, Albrecht Günther, et al.. (2024). Brain death determination in patients with veno-arterial extracorporeal membrane oxygenation: A systematic study to address the Harlequin syndrome. Journal of Critical Care. 81. 154545–154545.
2.
Hoffmann, Olaf, et al.. (2024). Addition of quantitative MRI to the routine clinical care of patients with multiple sclerosis—Results from the MAGNON project. Brain and Behavior. 14(6). e3548–e3548. 2 indexed citations
3.
Giovannoni, Gavin, Enrique Álvarez, Olaf Hoffmann, et al.. (2023). Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis. Digital Health. 9. 589817243–589817243. 3 indexed citations
4.
Kramer, John F., Ralf A. Linker, David Paling, et al.. (2023). Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(4). 3100567016–3100567016. 2 indexed citations
7.
Hoffmann, Olaf & Ralf Gold. (2021). Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose. Der Nervenarzt. 92(10). 1052–1060. 2 indexed citations
8.
Ziemssen, Tjalf, Gavin Giovannoni, Enrique Álvarez, et al.. (2021). Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey. Journal of Medical Internet Research. 23(10). e29558–e29558. 9 indexed citations
10.
Dörr, Jan, Priscilla Bäcker‐Koduah, Klaus‐Dieter Wernecke, et al.. (2020). High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(1). 2455323442–2455323442. 35 indexed citations
11.
Hoffmann, Olaf, et al.. (2020). Diagnostik des irreversiblen Hirnfunktionsausfalls. Der Anaesthesist. 70(7). 563–572. 1 indexed citations
12.
Hoffmann, Olaf & Florian Masuhr. (2016). Apparative Verfahren in der Hirntoddiagnostik. Der Nervenarzt. 87(2). 169–178. 4 indexed citations
13.
Preuße, Corinna, Yves Allenbach, Olaf Hoffmann, et al.. (2016). Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis. Acta Neuropathologica Communications. 4(1). 45–45. 46 indexed citations
14.
Salih, Farid, Martin Holtkamp, Stephan A. Brandt, et al.. (2016). Intracranial pressure and cerebral perfusion pressure in patients developing brain death. Journal of Critical Care. 34. 1–6. 19 indexed citations
15.
Hoffmann, Olaf & Florian Masuhr. (2015). Use of Observational Periods or Ancillary Tests in the Determination of Brain Death in Germany. European Neurology. 74(1-2). 11–17. 14 indexed citations
16.
Ivanova, Anna, et al.. (2010). Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system. BMC Developmental Biology. 10(1). 77–77. 9 indexed citations
17.
Freyer, Dorette, et al.. (2010). Inflammation Stimulates Thrombopoietin (Tpo) Expression in Rat Brain-Derived Microvascular Endothelial Cells, but Suppresses Tpo in Astrocytes and Microglia. Journal of Interferon & Cytokine Research. 30(7). 465–469. 11 indexed citations
18.
Hoffmann, Olaf. (2003). Zelluläre und molekulare Mechanismen der Tumormetastasierung in den Knochen. Journal für Kardiologie (Krause & Pachernegg GmbH). 10(2). 12–15. 1 indexed citations
19.
Rieger, Andreas, Nikolai G. Rainov, Heinrich Ebel, et al.. (1997). Factors predicting pituitary adenoma invasiveness in acromegalic patients. Neurosurgical Review. 20(3). 182–187. 17 indexed citations
20.
Jendroska, K., Olaf Hoffmann, & Stephan Patt. (1997). Amyloid β Peptide and Precursor Protein (APP) in Mild and Severe Brain Ischemia. Annals of the New York Academy of Sciences. 826(1). 401–405. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026